Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women
Open Access
- 14 July 2012
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (8), 1749-1756
- https://doi.org/10.2337/dc11-1838
Abstract
OBJECTIVE: Metabolite predictors of deteriorating glucose tolerance may elucidate the pathogenesis of type 2 diabetes. We investigated associations of circulating metabolites from high-throughput profiling with fasting and postload glycemia cross-sectionally and prospectively on the population level. RESEARCH DESIGN AND METHODS: Oral glucose tolerance was assessed in two Finnish, population-based studies consisting of 1,873 individuals (mean age 52 years, 58% women) and reexamined after 6.5 years for 618 individuals in one of the cohorts. Metabolites were quantified by nuclear magnetic resonance spectroscopy from fasting serum samples. Associations were studied by linear regression models adjusted for established risk factors. RESULTS: Nineteen circulating metabolites, including amino acids, gluconeogenic substrates, and fatty acid measures, were cross-sectionally associated with fasting and/or postload glucose (P < 0.001). Among these metabolic intermediates, branched-chain amino acids, phenylalanine, and α1-acid glycoprotein were predictors of both fasting and 2-h glucose at 6.5-year follow-up (P < 0.05), whereas alanine, lactate, pyruvate, and tyrosine were uniquely associated with 6.5-year postload glucose (P = 0.003–0.04). None of the fatty acid measures were prospectively associated with glycemia. Changes in fatty acid concentrations were associated with changes in fasting and postload glycemia during follow-up; however, changes in branched-chain amino acids did not follow glucose dynamics, and gluconeogenic substrates only paralleled changes in fasting glucose. CONCLUSIONS: Alterations in branched-chain and aromatic amino acid metabolism precede hyperglycemia in the general population. Further, alanine, lactate, and pyruvate were predictive of postchallenge glucose exclusively. These gluconeogenic precursors are potential markers of long-term impaired insulin sensitivity that may relate to attenuated glucose tolerance later in life.Keywords
This publication has 39 references indexed in Scilit:
- Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasmaNature Genetics, 2011
- Limited Overlap Between Intermediate Hyperglycemia as Defined by A1C 5.7–6.4%, Impaired Fasting Glucose, and Impaired Glucose ToleranceDiabetes Care, 2011
- Differential Metabolic Impact of Gastric Bypass Surgery Versus Dietary Intervention in Obese Diabetic Subjects Despite Identical Weight LossScience Translational Medicine, 2011
- Metabolite profiles and the risk of developing diabetesNature Medicine, 2011
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Gender Difference Among Smoking, Adiponectin, and High-Sensitivity C-Reactive ProteinAmerican Journal of Preventive Medicine, 2008
- Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose ConcentrationsDiabetes, 2008
- Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Mitochondrial Overload and Incomplete Fatty Acid Oxidation Contribute to Skeletal Muscle Insulin ResistanceCell Metabolism, 2008
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007